Expert Review of Pharmacoeconomics and Outcomes Research This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A projected cost-utility analysis of avacopan for the treatment of antineutrophil cytoplasmic antibody-associated vasculitis in Spain
CONCLUSIONS: Avacopan is a cost-effective option for patients with severe, active AAV compared to GC in Spain.PMID:38126738 | DOI:10.1080/14737167.2023.2297790 (Source: Expert Review of Pharmacoeconomics and Outcomes Research)
Source: Expert Review of Pharmacoeconomics and Outcomes Research - December 21, 2023 Category: Health Management Authors: Manuel Mac ía Montserrat D íaz-Encarnación Roser Solans-Laqu é Elisenda Pomares Mallol Alejandra Garc ía Castells Cristina Escribano Antonio Ram írez de Arellano Source Type: research

What to expect in 2024: important health economics and outcomes research (HEOR) trends
Expert Rev Pharmacoecon Outcomes Res. 2023 Dec 21:1-8. doi: 10.1080/14737167.2023.2292838. Online ahead of print.NO ABSTRACTPMID:38126707 | DOI:10.1080/14737167.2023.2292838 (Source: Expert Review of Pharmacoeconomics and Outcomes Research)
Source: Expert Review of Pharmacoeconomics and Outcomes Research - December 21, 2023 Category: Health Management Authors: Ivo Abraham Mickael Hiligsmann Kenneth K C Lee Leslie Citrome Giorgio L Colombo Mike Gregg Source Type: research

Improved medication adherence in COPD patients using tiotropium or tiotropium olodaterol with the HealthPrize digital behavior change program
CONCLUSIONS: Program participants showed improved COPD medication adherence and persistence compared to nonparticipants.PMID:38116664 | DOI:10.1080/14737167.2023.2296561 (Source: Expert Review of Pharmacoeconomics and Outcomes Research)
Source: Expert Review of Pharmacoeconomics and Outcomes Research - December 20, 2023 Category: Health Management Authors: Katrina S Firlik Vamshi Ruthwik Anupindi Vincent Hayes Mitchell DeKoven Asif Shaikh Jessica Franchino-Elder Source Type: research

Systematic review of the impact of health care expenditure on health outcome measures: implications for cost-effectiveness thresholds
CONCLUSIONS: The commonly used CET of GDPPC seems to be too high for all countries, but especially low-to-middle income countries where the potential health losses from misallocation of the same money are greater.Registration: The review protocol was published and registered in PROSPERO (CRD42020147276).PMID:38112068 | DOI:10.1080/14737167.2023.2296562 (Source: Expert Review of Pharmacoeconomics and Outcomes Research)
Source: Expert Review of Pharmacoeconomics and Outcomes Research - December 19, 2023 Category: Health Management Authors: Mac Ardy Junio Gloria Montarat Thavorncharoensap Usa Chaikledkaew Sitaporn Youngkong Ammarin Thakkinstian Nathorn Chaiyakunapruk Jessica Ochalek Anthony J Culyer Source Type: research

Impact of single-pill combinations versus free-equivalent combinations on adherence and persistence in patients with hypertension and dyslipidemia: a systematic literature review and meta-analysis
CONCLUSIONS: SPC use resulted in significantly improved adherence, persistence, and SBP levels compared with FEC in patients with hypertension. The findings support SPC use in reducing the burden of hypertension and dyslipidemia.PMID:38088763 | DOI:10.1080/14737167.2023.2293199 (Source: Expert Review of Pharmacoeconomics and Outcomes Research)
Source: Expert Review of Pharmacoeconomics and Outcomes Research - December 13, 2023 Category: Health Management Authors: Andr é Pascal Kengne Jean-Baptiste Bri ère Pauline Le Nouveau Petya Kodjamanova Petar Atanasov Maryse Kochoedo Omar Irfan Zeba M Khan Source Type: research

Evaluation of Antimicrobial Stewardship Programs and antibiotic prescribing patterns among physicians in ambulatory care settings in Jordan
CONCLUSION: It was fair adoption of the core elements in the ambulatory care settings among Jordanian physicians. Progress necessitates a comprehensive strategy tailored to the needs of the health system.PMID:38064312 | DOI:10.1080/14737167.2023.2293197 (Source: Expert Review of Pharmacoeconomics and Outcomes Research)
Source: Expert Review of Pharmacoeconomics and Outcomes Research - December 8, 2023 Category: Health Management Authors: Mera A Ababneh Hana Abujuma Shoroq Altawalbeh Saddam Al Demour Source Type: research

The role of insurance policies in the drug pricing landscape
Expert Rev Pharmacoecon Outcomes Res. 2023 Dec 8:1-14. doi: 10.1080/14737167.2023.2292693. Online ahead of print.ABSTRACTINTRODUCTION: This overview paper aims at summarizing and analyzing the available literature on healthcare system organization and pricing policies of 11 European countries, comparing them to the Bulgarian pharmaceutical system. The countries were selected based on the reference basket for the pricing of pharmaceuticals in Bulgaria - Belgium, Greece, Spain, Italy, Latvia, Lithuania, Romania, Slovakia, Slovenia, and France.AREAS COVERED: In the first part, we explore the health system models in the above-...
Source: Expert Review of Pharmacoeconomics and Outcomes Research - December 8, 2023 Category: Health Management Authors: Alexandra Savova Manoela Manova Konstantin Tachkov Guenka Petrova Source Type: research

Evaluation of Antimicrobial stewardship Programs and antibiotic prescribing patterns among physicians in ambulatory care settings in Jordan
CONCLUSION: It was fair adoption of the core elements in the ambulatory care settings among Jordanian physicians. Progress necessitates a comprehensive strategy tailored to the needs of the health system.PMID:38064312 | DOI:10.1080/14737167.2023.2293197 (Source: Expert Review of Pharmacoeconomics and Outcomes Research)
Source: Expert Review of Pharmacoeconomics and Outcomes Research - December 8, 2023 Category: Health Management Authors: Mera A Ababneh Hana Abujuma Shoroq Altawalbeh Saddam H Aldemour Source Type: research